Gilead Sciences, Inc. is a research-driven biopharmaceutical company dedicated to discovering, developing, and commercializing groundbreaking medications for areas of significant unmet medical need. Operating across the United States, Europe, and other international markets, the company offers a broad array of therapeutic solutions. Its product lineup notably includes treatments for human immunodeficiency virus (HIV) such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla.